๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada flag Canada ยท Delayed Price ยท Currency is CAD
5.71
-0.26 (-4.36%)
Nov 19, 2026, 4:00 PM EST

Medexus Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
107.6699.33108.33113.05108.176.7
Revenue Growth
3.42%-8.31%-4.18%4.59%40.93%-3.72%
Gross Profit
68.4563.8663.5165.0765.7743.67
Operating Income
7.895.8411.9212.798.49-12.38
Net Income
-1.24-2.392.25-0.211.22-2.88
Earnings Per Share
-0.04-0.070.08-0.010.06-0.15
EPS Growth
------

Revenue by Geography

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Canada
23.0424.5939.7235.8729.1624.7
United States
84.6274.7468.6177.1878.9452.01
Total
107.6699.33108.33113.05108.176.7

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
8.356.5223.975.2613.0710.02
Total Debt
26.2222.2637.1849.970.0854.86
Net Cash (Debt)
-17.87-15.74-13.21-44.64-57.01-44.84
Net Cash Growth
------
Net Cash Per Share
-0.56-0.49-0.50-2.00-2.78-2.26

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
16.318.8724.0318.71-1.44-1.18
Capital Expenditures
-0.07-0.15-0.18-0.05-0.06-0.1
Free Cash Flow
16.2218.7223.8518.66-1.51-1.28
Free Cash Flow Growth
1.41%-21.51%27.79%---

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
63.58%64.29%58.62%57.56%60.84%56.94%
Operating Margin
7.32%5.87%11.00%11.31%7.85%-16.13%
Pretax Margin
-0.78%-2.29%1.33%0.09%-4.66%-4.98%
Profit Margin
-1.15%-2.41%2.07%-0.19%1.13%-3.75%
FCF Margin
15.07%18.85%22.02%16.51%-1.39%-1.67%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--24.17-19.55-
Forward PE
10.427.4819.635.2143.8743.87
P/FCF Ratio
8.093.852.281.56--
PS Ratio
1.220.730.500.260.220.65